CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis (Q43159403)

15 November 2017

CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosis (English)

1 reference

Philipp Von Hundelshausen

15 November 2017

3

1 reference

15 November 2017

12

1 reference

15 November 2017

Ralf Weiskirchen

10

0 references

Maria Kowalska

7

object named as

M Anna Kowalska

1 reference

15 November 2017

8

Nikolaus Gassler

1 reference

15 November 2017

11

Christian Trautwein

1 reference

15 November 2017

9

Konrad L Streetz

1 reference

15 November 2017

4

Marie-Luise Berres

1 reference

15 November 2017

Mirko Moreno Zaldivar

1

object named as

Mirko Moreno Zaldivar

1 reference

15 November 2017

13

Hermann E Wasmuth

1 reference

15 November 2017

Katrin Pauels

2

1 reference

15 November 2017

Petra Schmitz

5

1 reference

15 November 2017

Jörg Bornemann

6

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 April 2010

1 reference

15 November 2017

1 reference

15 November 2017

51

1 reference

15 November 2017

4

1 reference

15 November 2017

1345-1353

1 reference

American Gastroenterological Association technical review on the management of hepatitis C.

15 November 2017

1 reference

Mechanisms of hepatic fibrogenesis

21 January 2018

1 reference

Cellular and molecular mechanisms of fibrosis

21 January 2018

1 reference

Immune interactions in hepatic fibrosis.

21 January 2018

1 reference

Coagulation and fibrosis in chronic liver disease

21 January 2018

1 reference

Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection

21 January 2018

1 reference

Thrombotic risk factors and extent of liver fibrosis in chronic viral hepatitis

21 January 2018

1 reference

Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies

21 January 2018

1 reference

Platelets mediate cytotoxic T lymphocyte-induced liver damage

21 January 2018

1 reference

Aggravation of viral hepatitis by platelet-derived serotonin

21 January 2018

1 reference

Platelet-derived serotonin mediates liver regeneration

21 January 2018

1 reference

Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease

21 January 2018

1 reference

Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice

21 January 2018

1 reference

Platelet chemokines in vascular disease

21 January 2018

1 reference

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4

21 January 2018

1 reference

Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

21 January 2018

1 reference

Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans

21 January 2018

1 reference

The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.

21 January 2018

1 reference

Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells

21 January 2018

1 reference

Pro-fibrogenic potential of PDGF-D in liver fibrosis

21 January 2018

1 reference

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

21 January 2018

1 reference

Platelet factor 4 mediates inflammation in experimental cerebral malaria

21 January 2018

1 reference

Liver fibrosis: cellular mechanisms of progression and resolution

21 January 2018

1 reference

The many roles of chemokines and chemokine receptors in inflammation

21 January 2018

1 reference

Chemokine-directed immune cell infiltration in acute and chronic liver disease

21 January 2018

1 reference

Blood platelet and monocyte activations and relation to stages of liver cirrhosis

21 January 2018

1 reference

Interactions between hepatic stellate cells and the immune system

21 January 2018

1 reference

Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury

21 January 2018

1 reference

Immune stimulation of hepatic fibrogenesis by CD8 cells and attenuation by transgenic interleukin-10 from hepatocytes

21 January 2018

1 reference

The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice

21 January 2018

1 reference

Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium

21 January 2018

1 reference

Platelet-derived chemokines in vascular biology

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.23435

1 reference

15 November 2017

1 reference